GettyImages-932533514-hero

Cancer Control

The Cancer Control program fosters and facilitates research designed to reduce cancer risk, improve outcomes and quality of life, and eliminate disparities across the cancer care continuum.

Joan Neuner, MD

Program Co-Lead

Joan Neuner, MD, MPH

Professor, Medicine (General Internal Medicine)

View Joan Neuner, MD, MPH Bio

Joan Neuner, MD

Program Co-Lead

Ann B. Nattinger, MD, MPH

Associate Provost for Research; Senior Associate Dean for Research, School of Medicine; Professor of Medicine, Lady Riders Professor of Breast Cancer Research; Principal Investigator, CHDS

View Ann Nattinger, MD, MPH Bio

Programs Aims

  • Identify biological and molecular factors and social determinants contributing to cancer burden
  • Identify health system mechanisms associated with inequities in cancer care access and outcomes
  • Develop and test interventions to decrease cancer burden and minimize inequities

Areas of Expertise

The Cancer Control program focuses on prevention and screening, quality of care, outcomes, survivorship and policy. It leverages the expertise of the Center for International Blood and Marrow Transplant Research which equips program researchers with data science to address outcomes and cancer disparities, and to make meaningful contributions to translational research.

  • Mechanistic studies in cancer disparities
  • Behavioral sciences
  • Screening and interventional studies with underserved populations
  • Biostatistics and data science
  • Policy-changing healthcare delivery research

Notable Science

Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients with Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial. (Atallah E, Flynn KE, et al) JAMA Oncol; January 2021

Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States. (Beyer KMM, Laud PW, Yen TWF, Kwarteng J, Nattinger AB., et al) J Clin Oncol; September 2021

Housing discrimination and racial cancer disparities among the 100 largest US metropolitan areas. (Beyer KMM, Laud PW, Nattinger AB, et al) Cancer; November 2019